approval · primary record
INSULIN RECOMBINANT HUMAN
FDA · BLA · 2026-05-29
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2026-05-29 |
| Brand | AFREZZA |
| Sponsor | MANNKIND |
| Route | INHALATION |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T03:29:31.792Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:INSULIN RECOMBINANT HUMAN:2026-05-29
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.